Free open access for verified healthcare professionals
Featured in
The power of an integrated approach to oncology research
0K+
Oncology publications indexed
Daily
Evidence updates
0+
Years of combined senior professional experience
SOLUTIONS
A faster path from evidence to value
Oncoscope combines Living Evidence with technology and expert-led services to accelerate evidence generation, strengthen value demonstration, and support decisions from early development through launch and beyond.
For Pharma
Turn evidence complexity into strategic advantage at scale
Oncoscope helps pharma teams navigate complex oncology landscapes, connecting intelligence across products, functions, and markets to inform strategy at scale.
Build & maintain living evidence. Continuously identify, synthesize, and update evidence across indications, treatments, and markets.
Generate value demonstration deliverables. Develop SLRs, evidence packages, value dossiers, economic models, and other evidence outputs for regulatory, HTA, and market access needs.
Support evidence strategy at scale. Identify evidence gaps, evaluate competitive landscapes, and align evidence generation across products, functions, and geographies
Turn evidence complexity into strategic advantage at scale
Oncoscope helps pharma teams navigate complex oncology landscapes, connecting intelligence across products, functions, and markets to inform strategy at scale.
Build & maintain living evidence. Continuously identify, synthesize, and update evidence across indications, treatments, and markets.
Generate value demonstration deliverables. Develop SLRs, evidence packages, value dossiers, economic models, and other evidence outputs for regulatory, HTA, and market access needs.
Support evidence strategy at scale. Identify evidence gaps, evaluate competitive landscapes, and align evidence generation across products, functions, and geographies
Oncoscope gives lean biotech teams access to the intelligence and expertise needed to prioritize investments, strengthen asset value, and move development forward without building large in-house capabilities.
Understand the landscape fast. Rapidly assess the disease, treatment, competitor, and evidence landscape around an emerging asset.
Prioritize the evidence that matters. Identify critical evidence gaps and focus limited resources on the evidence most important for development, differentiation, and future access.
Access expertise on demand. Extend internal capabilities with oncology, HEOR, and evidence-generation expertise to produce decision-ready analyses and value demonstration deliverables.
Oncoscope gives lean biotech teams access to the intelligence and expertise needed to prioritize investments, strengthen asset value, and move development forward without building large in-house capabilities.
Understand the landscape fast. Rapidly assess the disease, treatment, competitor, and evidence landscape around an emerging asset.
Prioritize the evidence that matters. Identify critical evidence gaps and focus limited resources on the evidence most important for development, differentiation, and future access.
Access expertise on demand. Extend internal capabilities with oncology, HEOR, and evidence-generation expertise to produce decision-ready analyses and value demonstration deliverables.
Expert capabilities accelerated by Living Evidence
Oncoscope brings together a continuously growing evidence foundation and deep oncology expertise to transform oncology complexity into meaningful value.
Living Evidence
Built once. Enriched daily. Reused across needs
Instead of recreating evidence for every project, Oncoscope builds and enriches a proprietary oncology evidence database through daily updates, making it more valuable with every new publication.
Deep expertise from evidence strategy to execution
Our oncology, HEOR, and market access experts apply this foundation to develop health economic analyses, models, strategic insights, and decision-ready deliverables across the product lifecycle.
